Bridgeway Capital Management, LLC Ironwood Pharmaceuticals Inc Transaction History
Bridgeway Capital Management, LLC
- $4.44 Billion
- Q3 2024
A detailed history of Bridgeway Capital Management, LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 311,200 shares of IRWD stock, worth $1.1 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
311,200
Previous 311,200
-0.0%
Holding current value
$1.1 Million
Previous $2.03 Million
36.96%
% of portfolio
0.03%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding IRWD
# of Institutions
238Shares Held
162MCall Options Held
11.2MPut Options Held
9.1K-
Black Rock Inc. New York, NY22.9MShares$80.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA22MShares$77.6 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$57.7 Million16.75% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.3MShares$39.7 Million0.11% of portfolio
-
State Street Corp Boston, MA9.92MShares$34.9 Million0.0% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $539M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...